Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer
Titel:
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer
Auteur:
Liu, J.F. Barry, W.T. Birrer, M. Lee, J.-M. Buckanovich, R.J. Fleming, G.F. Rimel, B.J. Buss, M.K. Nattam, S.R. Hurteau, J. Luo, W. Curtis, J. Whalen, C. Kohn, E.C. Ivy, S.P. Matulonis, U.A.